Cargando…
Severe Aortic Regurgitation of Early Degenerated Mitroflow Bioprosthesis: From Echocardiographic Diagnosis to Treatment with Valve-in-Valve Transcatheter Aortic Valve Implantation
Valve-in-Valve transcatheter aortic valve implantation (ViV TAVI) is emerging as an effective therapeutic option for bioprosthetic valve failure. Recently, concern has been raised for early valve deterioration of Mitroflow (Sorin) aortic bioprosthesis, with the development of prevalent stenosis. We...
Autores principales: | Pernigo, Matteo, Triggiani, Marco, Adamo, Marianna, Pasini, Gian Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230156/ https://www.ncbi.nlm.nih.gov/pubmed/34221889 http://dx.doi.org/10.4103/jcecho.jcecho_129_20 |
Ejemplares similares
-
Transcatheter Valve-in-Valve Implantation in an Aortic Bioprosthesis With Severe Regurgitation and a Challenging Aortic Anatomy
por: Marchese, Alfredo, et al.
Publicado: (2022) -
Mitroflow Aortic Bioprosthesis Failure in Type B Aortic Dissection: Preventive Left Main Stenting in Transapical Transcatheter Aortic Valve Implantation Strategy
por: Chiariello, Giovanni Alfonso, et al.
Publicado: (2018) -
Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity
por: Waziri, Farhad, et al.
Publicado: (2019) -
Improvement of Mitral Regurgitation after Transapical Transcatheter Aortic Valve Bioprosthesis Implantation
por: Filho, Heraldo G Lobo, et al.
Publicado: (2015) -
Transcatheter heart valve stuck in a surgical bioprosthesis during valve-in-valve transcatheter aortic valve replacement
por: Kawaguchi, Masanori, et al.
Publicado: (2023)